2021
DOI: 10.1111/ijlh.13658
|View full text |Cite
|
Sign up to set email alerts
|

Minimizing cost associated with management of heparin‐induced thrombocytopenia: A cost analysis of various laboratory testing models

Abstract: Introduction: Management of patients with suspected heparin-induced thrombocytopenia (HIT) can lead to significant costs. Reported cost-saving initiatives have focused on minimizing inappropriate testing in low-risk patients and optimizing alternative anticoagulant selection. We sought to further investigate how utilizing various HIT laboratory testing models would impact total cost of testing and alternative anticoagulant use.Methods: Utilizing a retrospective cohort of adult patients tested for HIT over thre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 14 publications
0
0
0
Order By: Relevance